Cargando…
Patients with Congenital Low-Flow Vascular Malformation Treated with Low Dose Sirolimus
INTRODUCTION: Patients with congenital vascular malformations often suffer from an impaired quality of life (QoL) because of pain and functional disabilities. Previous studies have shown that the mTOR inhibitor sirolimus can reduce complaints and improve QoL in some patients. High target levels of s...
Autores principales: | Harbers, Veroniek E. M., Rongen, Gerard A. P. J. M., van der Vleuten, Carine J. M., Verhoeven, Bas H., de Laat, Peter C. J., van der Horst, Chantal M. A. M., Klein, Willemijn M., Schultze Kool, Leo J., Loo, D. Maroeska W. M. te |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190005/ https://www.ncbi.nlm.nih.gov/pubmed/34003452 http://dx.doi.org/10.1007/s12325-021-01758-y |
Ejemplares similares
-
Clinical differences in sirolimus treatment with low target levels between children and adults with vascular malformations – A nationwide trial
por: Harbers, Veroniek E. M., et al.
Publicado: (2023) -
Magnitude and relevance of change in health-related quality of life in patients with vascular malformations treated with sirolimus
por: Harbers, Veroniek E. M., et al.
Publicado: (2023) -
Effective low–dose sirolimus regimen for kaposiform haemangioendothelioma with Kasabach–Merritt phenomenon in young infants
por: Harbers, Veroniek E. M., et al.
Publicado: (2022) -
Health-related quality of life in children with congenital vascular malformations
por: Bouwman, Frédérique C. M., et al.
Publicado: (2023) -
Lymphatic malformations in children: treatment outcomes of sclerotherapy in a large cohort
por: Bouwman, Frédérique C. M., et al.
Publicado: (2020)